The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter phase II study of avelumab in patients with locally advanced or metastatic penile cancer (PC) who are unfit for, or have progressed on or after platinum-based chemotherapy: (ALPACA).
 
Husam Alqaisi
No Relationships to Disclose
 
Eric Winquist
Honoraria - Amgen; Bayer; Eisai; Merck; Roche
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
 
Som Mukherjee
Honoraria - AstraZeneca
Consulting or Advisory Role - Merck; Novartis/Pfizer; Roche
Travel, Accommodations, Expenses - Amgen
 
Christina M. Canil
Honoraria - Janssen
Consulting or Advisory Role - Astellas Medivation; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Merck; Pfizer; Roche
Research Funding - Eisai (Inst)
Travel, Accommodations, Expenses - Amgen; Pfizer; Sanofi
 
Nazanin Fallah-Rad
Honoraria - Bayer; Ipsen
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - Nektar
 
Srikala S. Sridhar
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Merck (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Research Funding - Bayer (Inst); Janssen (Inst)